AAAAAA

   
Results: 1-16 |
Results: 16
ACOUSTIC-WAVES AND THE REAL-TIME STUDY OF BIOCHEMICAL MACROMOLECULES AT THE LIQUID SOLID INTERFACE/
Authors: CAVIC BA CHU FL FURTADO LM GHAFOURI S HAYWARD GL MACK DP MCGOVERN ME SU H THOMPSON M
Citation: Ba. Cavic et al., ACOUSTIC-WAVES AND THE REAL-TIME STUDY OF BIOCHEMICAL MACROMOLECULES AT THE LIQUID SOLID INTERFACE/, Faraday discussions, (107), 1997, pp. 159-176
GENOSENSOR TECHNOLOGY AND THE DETECTION OF INTERFACIAL NUCLEIC-ACID CHEMISTRY
Authors: YANG MS MCGOVERN ME THOMPSON M
Citation: Ms. Yang et al., GENOSENSOR TECHNOLOGY AND THE DETECTION OF INTERFACIAL NUCLEIC-ACID CHEMISTRY, Analytica chimica acta, 346(3), 1997, pp. 259-275
PRAVASTATIN LIMITATION OF ATHEROSCLEROSIS IN THE CORONARY-ARTERIES (PLAC-I) - REDUCTION IN ATHEROSCLEROSIS PROGRESSION AND CLINICAL EVENTS
Authors: PITT B MANCINI GBJ ELLIS SG ROSMAN HS PARK JS MCGOVERN ME
Citation: B. Pitt et al., PRAVASTATIN LIMITATION OF ATHEROSCLEROSIS IN THE CORONARY-ARTERIES (PLAC-I) - REDUCTION IN ATHEROSCLEROSIS PROGRESSION AND CLINICAL EVENTS, Journal of the American College of Cardiology, 26(5), 1995, pp. 1133-1139
EFFICACY AND SAFETY OF PRAVASTATIN IN THE TREATMENT OF PATIENTS WITH TYPE-I OR TYPE-II DIABETES-MELLITUS AND HYPERCHOLESTEROLEMIA
Authors: RASKIN P GANDA OP SCHWARTZ S WILLARD D ROSENSTOCK J LODEWICK PA CRESSMAN MD PHILLIPSON B WEINER B MCGOVERN ME NORTON JM CUCINOTTA GG BEHOUNEK BD
Citation: P. Raskin et al., EFFICACY AND SAFETY OF PRAVASTATIN IN THE TREATMENT OF PATIENTS WITH TYPE-I OR TYPE-II DIABETES-MELLITUS AND HYPERCHOLESTEROLEMIA, The American journal of medicine, 99(4), 1995, pp. 362-369
REDUCTION IN CORONARY EVENTS DURING TREATMENT WITH PRAVASTATIN
Authors: FURBERG CD PITT B BYINGTON RP PARK JS MCGOVERN ME
Citation: Cd. Furberg et al., REDUCTION IN CORONARY EVENTS DURING TREATMENT WITH PRAVASTATIN, The American journal of cardiology, 76(9), 1995, pp. 60-63
PRAVASTATIN, LIPIDS, AND ATHEROSCLEROSIS IN THE CAROTID ARTERIES (PLAC-II)
Authors: CROUSE JR BYINGTON RP BOND MG ESPELAND MA CRAVEN TE SPRINKLE JW MCGOVERN ME FURBERG CD
Citation: Jr. Crouse et al., PRAVASTATIN, LIPIDS, AND ATHEROSCLEROSIS IN THE CAROTID ARTERIES (PLAC-II), The American journal of cardiology, 75(7), 1995, pp. 455-459
PRAVASTATIN, LIPIDS, AND ATHEROSCLEROSIS IN THE CAROTID ARTERIES (VOL75, PG 455, 1995)
Authors: CROUSE JR BYINGTON RP BOND MG ESPELAND MA CRAVEN TE SPRINKLE JW MCGOVERN ME FURBERG CD
Citation: Jr. Crouse et al., PRAVASTATIN, LIPIDS, AND ATHEROSCLEROSIS IN THE CAROTID ARTERIES (VOL75, PG 455, 1995), The American journal of cardiology, 75(12), 1995, pp. 862-862
ROLE OF SOLVENT ON THE SILANIZATION OF GLASS WITH OCTADECYLTRICHLOROSILANE
Authors: MCGOVERN ME KALLURY KMR THOMPSON M
Citation: Me. Mcgovern et al., ROLE OF SOLVENT ON THE SILANIZATION OF GLASS WITH OCTADECYLTRICHLOROSILANE, Langmuir, 10(10), 1994, pp. 3607-3614
PRAVASTATIN LIMITATION OF ATHEROSCLEROSIS IN THE CORONARY-ARTERIES (PLAC-I)
Authors: PITT B MANCINI GBJ ELLIS SG ROSMAN HS MCGOVERN ME
Citation: B. Pitt et al., PRAVASTATIN LIMITATION OF ATHEROSCLEROSIS IN THE CORONARY-ARTERIES (PLAC-I), Journal of the American College of Cardiology, 1994, pp. 10000131-10000131
PEPTIDE MODELS .10. TOPOLOGICAL FEATURES OF MOLECULAR MECHANICS AND AB-INITIO 6D-RAMACHANDRAN MAPS - CONFORMATIONAL DATA FOR AC-L-ALA-L-ALA-L-ALA-NHME AND FOR-L-ALA-L-ALA-L-ALA-NH2
Authors: CHEUNG M MCGOVERN ME JIN T ZHAO DC MCALLISTER MA FARKAS O PERCZEL A CSASZAR P CSIZMADIA IG
Citation: M. Cheung et al., PEPTIDE MODELS .10. TOPOLOGICAL FEATURES OF MOLECULAR MECHANICS AND AB-INITIO 6D-RAMACHANDRAN MAPS - CONFORMATIONAL DATA FOR AC-L-ALA-L-ALA-L-ALA-NHME AND FOR-L-ALA-L-ALA-L-ALA-NH2, Journal of molecular structure. Theochem, 115(2), 1994, pp. 151-224
A MULTINATIONAL STUDY OF THE EFFECTS OF LOW-DOSE PRAVASTATIN IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS AND HYPERCHOLESTEROLEMIA
Authors: BEHOUNEK BD MCGOVERN ME KASSLERTAUB KB MARKOWITZ JS BERGMAN M BEDARD J LEITER L OLEARY TJ TAN MH TILDESLEY HD",BERTHEZENE,KREMPF,MOINADE,PASSA,WEMEAU,BIESENBACH,DAMMANN,ERHARD,HEBBELN,HUTH,MAHLA,MARTENS,PATSCH,SCHNEIDER,SCHOLTEN,TEUBER,WEISWEILER,"BARON H",KLEINMAN,"SEGAL P YESHURON D AWUNORRENNER C CONALGEN JC FEEK CM
Citation: Bd. Behounek et al., A MULTINATIONAL STUDY OF THE EFFECTS OF LOW-DOSE PRAVASTATIN IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS AND HYPERCHOLESTEROLEMIA, Clinical cardiology, 17(10), 1994, pp. 558-562
EFFICACY AND SAFETY OF PRAVASTATIN IN THE LONG-TERM TREATMENT OF ELDERLY PATIENTS WITH HYPERCHOLESTEROLEMIA
Authors: SANTINGA JT ROSMAN HS RUBENFIRE M MACIEJKO JJ KOBYLAK L MCGOVERN ME BEHOUNEK BD
Citation: Jt. Santinga et al., EFFICACY AND SAFETY OF PRAVASTATIN IN THE LONG-TERM TREATMENT OF ELDERLY PATIENTS WITH HYPERCHOLESTEROLEMIA, The American journal of medicine, 96(6), 1994, pp. 509-515
EFFECT OF FOOD ON PRAVASTATIN PHARMACOKINETICS AND PHARMACODYNAMICS
Authors: PAN HY DEVAULT AR BRESCIA D WILLARD DA MCGOVERN ME WHIGAN DB IVASHKIV E
Citation: Hy. Pan et al., EFFECT OF FOOD ON PRAVASTATIN PHARMACOKINETICS AND PHARMACODYNAMICS, International journal of clinical pharmacology, therapy and toxicology, 31(6), 1993, pp. 291-294
PRAVASTATIN EXPERIENCE IN ELDERLY AND NON-ELDERLY PATIENTS
Authors: MELLIES MJ DEVAULT AR KASSLERTAUB K MCGOVERN ME PAN HY
Citation: Mj. Mellies et al., PRAVASTATIN EXPERIENCE IN ELDERLY AND NON-ELDERLY PATIENTS, Atherosclerosis, 101(1), 1993, pp. 97-110
EFFECTS OF PRAVASTATIN IN PATIENTS WITH SERUM TOTAL CHOLESTEROL LEVELS FROM 5.2 TO 7.8 MMOL LITER (200 TO 300 MG DL) PLUS 2 ADDITIONAL ATHEROSCLEROTIC RISK-FACTORS
Authors: BEHOUNEK BD MARKOWITZ JS BERGMAN M MCGOVERN ME KASSLERTAUB KB VANHANEN H ELORANTA M JUVONEN J KANTOLA I KEKKI S KIVELA H KNUTAR F NISSEN M SALMI J SALONEN R TARPILA S TUNTURIHIHNALA H AMANN FW BERENDES G BONNER G DUBACH UC EGGSTEIN M FRANKENBERG HV FROER KL HOHL H HOPPE F KUMMER H MARZ W MOCCETTI T NOSEDA G REUTTER FW SCHWENKE R VOSSCHULTE G WAMBACH G WEIDMANN P BONNIER JJRM DEWEERD P HUIGE MC JANSEN LJ TERIJDT AJ TEVELDE K OLSSON AG LARSSON H ASPLUND J DAHLQVIST A LONNQVIST F FRITHZ G HOGLUND C KJELLSTROM T KUYLENSTIERNA J MOLLER B OSTERGREN J CRAMB R DAVIES J",IVERSON,"JOHNSTON GD MUNRO A PEACOCK I RITCHIE LD RITTER J RYLANCE PB SEVER PS SIMMONS RL
Citation: Bd. Behounek et al., EFFECTS OF PRAVASTATIN IN PATIENTS WITH SERUM TOTAL CHOLESTEROL LEVELS FROM 5.2 TO 7.8 MMOL LITER (200 TO 300 MG DL) PLUS 2 ADDITIONAL ATHEROSCLEROTIC RISK-FACTORS, The American journal of cardiology, 72(14), 1993, pp. 1031-1037
DESIGN AND RECRUITMENT IN THE UNITED-STATES OF A MULTICENTER QUANTITATIVE ANGIOGRAPHIC TRIAL OF PRAVASTATIN TO LIMIT ATHEROSCLEROSIS IN THECORONARY-ARTERIES (PLAC-I)
Authors: PITT B ELLIS SG MANCINI GBJ ROSMAN HS MCGOVERN ME
Citation: B. Pitt et al., DESIGN AND RECRUITMENT IN THE UNITED-STATES OF A MULTICENTER QUANTITATIVE ANGIOGRAPHIC TRIAL OF PRAVASTATIN TO LIMIT ATHEROSCLEROSIS IN THECORONARY-ARTERIES (PLAC-I), The American journal of cardiology, 72(1), 1993, pp. 31-35
Risultati: 1-16 |